Clinical & Experimental Cardiology

Clinical & Experimental Cardiology
Open Access

ISSN: 2155-9880

+44 1300 500008

Clinical & Experimental Cardiology : Citations & Metrics Report

Articles published in Clinical & Experimental Cardiology have been cited by esteemed scholars and scientists all around the world. Clinical & Experimental Cardiology has got h-index 14, which means every article in Clinical & Experimental Cardiology has got 14 average citations.

Following are the list of articles that have cited the articles published in Clinical & Experimental Cardiology.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010

Total published articles

60 111 60 56 72 27 53 76 88 61 72 136 96 61 13

Research, Review articles and Editorials

6 9 6 24 42 20 39 53 59 39 52 99 75 38 9

Research communications, Review communications, Editorial communications, Case reports and Commentary

44 102 54 32 30 7 14 23 29 22 21 37 21 23 4

Conference proceedings

24 25 41 43 3 49 398 389 515 204 157 126 26 33 0

Citations received as per Google Scholar, other indexing platforms and portals

143 212 54 63 88 70 62 294 304 211 147 75 29 93 0
Journal total citations count 2980
Journal impact factor 1.05
Journal 5 years impact factor 1.27
Journal cite score 1.34
Journal h-index 14
Journal h-index since 2019 9
Important citations (1711)

parsons xh (2012) an engraftable human embryonic stem cell neuronal lineage-specific derivative retains embryonic chromatin plasticity for scale-up cns regeneration. journal of regenerative medicine & tissue engineering 1.

parsons xh, parsons jf, moore (2012) genome-scale mapping of microrna signatures in human embryonic stem cell neurogenesis. molecular medicine & therapeutics 1.

o'neill hs, o'sullivan j, porteous (2016) a collagen cardiac patch incorporating alginate microparticles permits the controlled release of hgf and igf‐1 to enhance cardiac stem cell migration and proliferation. journal of tissue engineering and regenerative medicine.

micheu mm, scafa-udriste a, dorobantu (2016) bringing cardiac stem cell therapy from bench to bedside: lessons from the past and future perspectives. romanian journal of morphology and embryology. 57: 367-372

hsiao lc, perbellini f, gomes (2013) murine cardiosphere-derived cells are impaired by age but not by cardiac dystrophic dysfunction. stem cells and development. 23: 1027-1036

dixit p, katare r (2015) challenges in identifying the best source of stem cells for cardiac regeneration therapy. stem cell research & therapy 1: 26

Grunert m, dorn c, cui h, dunkel i, schulz k, schoenhals s, sun w, berger f, chen w, sperling sr. comparative dna methylation and gene expression analysis identifies novel genes for structural congenital heart diseases. cardiovascular research. 2016 oct 1;112(1):464-77.

Ruggiero d, nappo s, nutile t, sorice r, talotta f, giorgio e, bellenguez c, leutenegger al, liguori gl, ciullo m. genetic variants modulating cripto serum levels identified by genome-wide association study in cilento isolates. plos genetics. 2015 jan 28;11(1):e1004976.

Barnes rm, harris is, jaehnig ej, sauls k, sinha t, rojas a, schachterle w, mcculley dj, norris ra, black bl. mef2c regulates outflow tract alignment and transcriptional control of tdgf1. development. 2016 mar 1;143(5):774-9.

Klauzinska m, castro np, rangel mc, spike bt, gray pc, bertolette d, cuttitta f, salomon d. the multifaceted role of the embryonic gene cripto-1 in cancer, stem cells and epithelial-mesenchymal transition. inseminars in cancer biology 2014 dec 1 (vol. 29, pp. 51-58). academic press.

parsons xh (2016) human pluripotent stem cell-based plurixcel technology platforms provide stem cell treatment development and manufacturing innovations for progressing to the clinic. j regen ther.

parsons xh (2013) the designation of human cardiac stem cell therapy products for human trials. j clin trial cardiol.

parsons xh (2014) the openness of pluripotent epigenome–defining the genomic integrity of stemness for regenerative medicine. int j cancer ther oncol.

parsons xh (2016) direct conversion of pluripotent human embryonic stem cells under defined culture conditions into human neuronal or cardiomyocyte cell therapy derivatives. human embryonic stem cell protocols :299-318.

iop l, gerosa g (2015) guided tissue regeneration in heart valve replacement: from preclinical research to first-in-human trials. biomed research international. 2015

smit fe, dohmen pm (2014) bio-artificial heart as ultimate treatment of end-stage heart failure. medical science monitor basic research.

kibar f, ozturk og, ulu (2014) role of kir genes and genotypes in susceptibility to or protection against hepatitis b virus infection in a turkish cohort. medical science monitor: international medical journal of experimental and clinical research.

dohmen pm, da costa f, (2014) successful implantation of a decellularized equine pericardial patch into the systemic circulation. medical science monitor basic research.

dohmen pm (2012) tissue engineered aortic valve. hrs proceedings in intensive care and cardiovascular anesthesia. 4:89-93

qiu yuwei (2014) effects of spatial effects on cell interstitial and cardiomyocyte interactions. papers published in taiwan university clinical medicine research institute.

Top